Neumora Therapeutics Long Term Debt

Neumora Therapeutics (NMRA) currently reports a long-term debt of $41K as of June 2026. That compares with $340K in the prior-year period — down 87.9% year over year. Use the charts on this page to explore Neumora Therapeutics's long-term debt history and peer comparisons.

Neumora Therapeutics's long-term debt decreased from $340K to $41K — a 87.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neumora Therapeutics reported $41K in long-term debt as of June 2026. That compares with $340K in the prior-year period — down 87.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $41K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neumora Therapeutics, and consider following NMRA for alerts when major investors trade the stock.